Wasan lab develops novel oral formula... - Lung Conditions C...

Lung Conditions Community Forum

55,059 members65,847 posts

Wasan lab develops novel oral formulation to treat systemic fungal infections.

2greys profile image
0 Replies

The Wasan Laboratory in the Faculty of Pharmaceutical Sciences at the University of British Columbia in partnership with iCo Therapeutics Inc. (Vancouver BC, Canada) have developed a novel oral formulation of Amphotericin B to treat systemic fungal and parasitic infections. Amphotericin B is a polyene macrolide antibiotic used in the treatment of blood-borne fungal infections such as candidiasis and aspergillosis and parasitic infections such as visceral leishmaniasis.

news-medical.net/news/20200...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...

You may also like...

Table tennis consultant and Gp

he developed a really distressing cough , not Covid and not an infection , not the Aspergillosis...

staphylococcus aureus and pseudomonas

that the staph causes life threatening infections if not treated. As I had exams so I avoided going...